ATE380467T1 - Expression von ausgeschiedenem, menschlichem alpha-fetoprotein in transgenen tieren - Google Patents

Expression von ausgeschiedenem, menschlichem alpha-fetoprotein in transgenen tieren

Info

Publication number
ATE380467T1
ATE380467T1 AT00903133T AT00903133T ATE380467T1 AT E380467 T1 ATE380467 T1 AT E380467T1 AT 00903133 T AT00903133 T AT 00903133T AT 00903133 T AT00903133 T AT 00903133T AT E380467 T1 ATE380467 T1 AT E380467T1
Authority
AT
Austria
Prior art keywords
fetoprotein
expression
human alpha
transgenic animals
excreted human
Prior art date
Application number
AT00903133T
Other languages
English (en)
Inventor
Stace Lindsay
Robert Mulroy
Daniel Semeniuk
Original Assignee
Merrimack Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrimack Pharmaceuticals Inc filed Critical Merrimack Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE380467T1 publication Critical patent/ATE380467T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Environmental Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Animal Husbandry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
AT00903133T 1999-01-06 2000-01-06 Expression von ausgeschiedenem, menschlichem alpha-fetoprotein in transgenen tieren ATE380467T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11499599P 1999-01-06 1999-01-06

Publications (1)

Publication Number Publication Date
ATE380467T1 true ATE380467T1 (de) 2007-12-15

Family

ID=22358708

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00903133T ATE380467T1 (de) 1999-01-06 2000-01-06 Expression von ausgeschiedenem, menschlichem alpha-fetoprotein in transgenen tieren

Country Status (10)

Country Link
US (3) US20110077208A1 (de)
EP (2) EP1958503A3 (de)
JP (1) JP2002534077A (de)
AT (1) ATE380467T1 (de)
AU (1) AU2492400A (de)
CA (1) CA2354638C (de)
DE (1) DE60037397T2 (de)
DK (1) DK1148779T3 (de)
ES (1) ES2298127T3 (de)
WO (1) WO2000040693A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208576B2 (en) * 1999-01-06 2007-04-24 Merrimack Pharmaceuticals, Inc. Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
AU5798600A (en) * 1999-07-12 2001-01-30 Universite Libre De Bruxelles Non-human genetically modified mammal lacking the alpha-fetoprotein
US7022892B1 (en) 1999-07-12 2006-04-04 Universite Libre De Bruxelles Non-human genetically modified mammal lacking the alpha-fetoprotein
WO2003054182A2 (en) * 2001-12-21 2003-07-03 Nexia Biotechnologies, Inc. Production of butyrylcholinesterases in transgenic mammals
CA2784861A1 (en) 2009-12-21 2011-07-14 Pharmathene, Inc. Recombinant butyrylcholinesterases and truncates thereof
CN102526389A (zh) * 2012-03-09 2012-07-04 王利伟 一种治疗肌无力肌萎缩的中药
TW201512001A (zh) * 2013-09-30 2015-04-01 Hon Hai Prec Ind Co Ltd 安全駕駛監控系統、方法及車

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873292A (en) 1984-12-28 1989-10-10 Research Development Corporation Of Japan Antithrombogenic synthetic polymer and process for its preparation
DE3751873T2 (de) * 1986-04-09 1997-02-13 Genzyme Corp Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
US5366894A (en) 1986-06-30 1994-11-22 Pharmaceutical Proteins Limited Peptide production
GB8615942D0 (en) * 1986-06-30 1986-08-06 Animal & Food Research Council Peptide production
US4873316A (en) * 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
JPH0246284A (ja) * 1988-07-25 1990-02-15 Sclavo Spa ヒトα−フェトプロテインの製法
WO1991005041A1 (en) * 1989-09-26 1991-04-18 Townes Tim M Erythroid-specific gene expression system
US5633076A (en) * 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
US5831141A (en) 1991-01-11 1998-11-03 United States Of America As Represented By The Department Of Health And Human Services Expression of a heterologous polypeptide in mammary tissue of transgenic non-human mammals using a long whey acidic protein promoter
AU1228592A (en) 1991-01-11 1992-08-17 American Red Cross Expression of active human protein c in mammary tissue of transgenic animals
JPH06509474A (ja) 1991-07-31 1994-10-27 ローヌ−プーラン・ローラー・インターナシヨナル（ホールデイングス）インコーポレイテツド 蛋白質のトランスジェニック生産
CA2120131A1 (en) 1991-09-27 1994-05-11 Robert A. Murgita Expression and purification of cloned human alpha-fetoprotein
US5667839A (en) * 1993-01-28 1997-09-16 Collagen Corporation Human recombinant collagen in the milk of transgenic animals
DK75393D0 (da) * 1993-06-24 1993-06-24 Symbicom Ab Production of protein
US5804407A (en) * 1993-11-04 1998-09-08 University Technologies International, Inc. Method of expressing genes in mammalian cells
US5827690A (en) 1993-12-20 1998-10-27 Genzyme Transgenics Corporatiion Transgenic production of antibodies in milk
US5639940A (en) 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
FR2717500A1 (fr) * 1994-03-17 1995-09-22 Pasteur Institut Procédé d'infection de cellules rénales par un un vecteur recombinant.
GB9406974D0 (en) * 1994-04-08 1994-06-01 Pharmaceutical Proteins Ltd Transgenic production
US5533976A (en) 1994-07-15 1996-07-09 Allergan, Inc. Reusable cartridge assembly for a phaco machine
US5880327A (en) * 1994-09-21 1999-03-09 American National Red Cross Transgenic mammals expressing human coagulation factor VIII
US5780009A (en) 1995-01-20 1998-07-14 Nexia Biotechnologies, Inc. Direct gene transfer into the ruminant mammary gland
AU700975B2 (en) * 1995-01-24 1999-01-14 Merrimack Pharmaceuticals, Inc. Recombinant human alpha-fetoprotein and uses thereof
US5843705A (en) 1995-02-21 1998-12-01 Genzyme Transgenic Corporation Transgenically produced antithrombin III
US5824543A (en) * 1995-06-05 1998-10-20 New York University Method for expression and isolation of biologically active molecules in urine using a mouse uroplakin-II promoter
US6118045A (en) * 1995-08-02 2000-09-12 Pharming B.V. Lysosomal proteins produced in the milk of transgenic animals
US6268487B1 (en) * 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
JPH1084981A (ja) * 1996-07-26 1998-04-07 Y S New Technol Kenkyusho:Kk 乳腺発現用ベクター
DE69841459D1 (en) * 1997-02-14 2010-03-11 American Nat Red Cross Expression des active human factor ix im brustdrüsengewebe transgener tiere
WO2000015772A2 (en) * 1998-09-16 2000-03-23 Nexia Biotechnologies, Inc. Recombinant protein production in urine

Also Published As

Publication number Publication date
US20130131317A1 (en) 2013-05-23
EP1148779B1 (de) 2007-12-12
CA2354638C (en) 2013-03-19
JP2002534077A (ja) 2002-10-15
AU2492400A (en) 2000-07-24
US20120259093A1 (en) 2012-10-11
DE60037397T2 (de) 2008-06-05
WO2000040693A3 (en) 2000-09-28
CA2354638A1 (en) 2000-07-13
DE60037397D1 (de) 2008-01-24
WO2000040693A2 (en) 2000-07-13
EP1958503A3 (de) 2008-11-26
DK1148779T3 (da) 2008-03-25
ES2298127T3 (es) 2008-05-16
EP1148779A2 (de) 2001-10-31
EP1958503A2 (de) 2008-08-20
US20110077208A1 (en) 2011-03-31
EP1148779A4 (de) 2003-02-12

Similar Documents

Publication Publication Date Title
ATE237234T1 (de) Haustierfutter geeignet zur zahnpflege der haustiere
EP1181390A4 (de) 27 menschliche, sekretierte proteine
EP1392817A4 (de) Sekretierte humanproteine
EP1212342A4 (de) 18 human-sekretierte proteine
EP1192176A4 (de) 49 menschliche sekretierte proteine
DE60037397D1 (de) Expression von ausgeschiedenem, menschlichem alpha-fetoprotein in transgenen tieren
EP1192278A4 (de) 48 menschliche sekretierte proteine
EP1175439A4 (de) 49 humane sekretierte proteine
EP1165827A4 (de) 45 humane sekretierte proteine
EP1159284A4 (de) 33 human sekrteierte proteine
EP1189917A4 (de) 48 menschliche sekretierte proteine
EP1185543A4 (de) 50 human-sekretierte proteine
EP1002132A4 (de) Humane sekretierte proteine
EP1173477A4 (de) 49 humane sekretierte Proteine
EP1206573A4 (de) 26 humane sekretionsproteine
EP1144614A4 (de) Menschliche, ausgeschiedene proteine
EP1169332A4 (de) 49 human sekrtierte proteine
EP1171460A4 (de) 48 menschliche sekretierte proteine
EP1165828A4 (de) 50 menschliche sekretierte proteine
EP1185285A4 (de) 49 humane sekretierte proteine
EP1159287A4 (de) 50 menschliche sekretierte proteine
EP1165591A4 (de) 47 menschliche sekretierte proteine
EP1165123A4 (de) 48 menschliche sekretierte proteine
EP1165587A4 (de) 50 menschlich sekretierte proteine
DZ2803A1 (fr) Polypeptide de la protéine c humaine.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties